New Solutions for Type 2 Diabetes Mellitus: The Role of Pioglitazone.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 1, p. 1, doi. 10.2165/00019053-200220001-00001
- By:
- Publication type:
- Article
Works matching IS 11707690 AND DT 2002 AND VI 20 AND IP 1
Results: 16
1
2
The Role of Models Within Economic Analysis: Focus on Type 2 Diabetes Mellitus.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 1, p. 11, doi. 10.2165/00019053-200220001-00002
- By:
- Publication type:
- Article
3
A Guideline for the Use of Pharmacoeconomic Models of Diabetes Treatment in the US Managed-Care Environment.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 1, p. 21, doi. 10.2165/00019053-200220001-00003
- By:
- Publication type:
- Article
4
Economic Evaluation of Pioglitazone Hydrochloride in the Management of Type 2 Diabetes Mellitus in Canada.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 1, p. 31, doi. 10.2165/00019053-200220001-00004
- By:
- Publication type:
- Article
5
Applications of Economic Models in Healthcare: The Introduction of Pioglitazone in Sweden.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 1, p. 43, doi. 10.2165/00019053-200220001-00005
- By:
- Publication type:
- Article
6
Applications of economic models in healthcare: the introduction of pioglitazone in Sweden.
- Published in:
- 2002
- By:
- Publication type:
- journal article
7
Economic evaluation of pioglitazone hydrochloride in the management of type 2 diabetes mellitus in Canada.
- Published in:
- 2002
- By:
- Publication type:
- journal article
8
A guideline for the use of pharmacoeconomic models of diabetes treatment in the US managed-care environment.
- Published in:
- 2002
- By:
- Publication type:
- journal article
9
The role of models within economic analysis: focus on type 2 diabetes mellitus.
- Published in:
- 2002
- By:
- Publication type:
- journal article
10
New solutions for type 2 diabetes mellitus: the role of pioglitazone.
- Published in:
- 2002
- By:
- Publication type:
- journal article
11
Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis.
- Published in:
- 2002
- By:
- Publication type:
- journal article
12
Pharmacy benefit management: enhancing the applicability of pharmacoeconomics for optimal decision making.
- Published in:
- 2002
- By:
- Publication type:
- journal article
13
Onychomycosis: health-related quality of life considerations.
- Published in:
- 2002
- By:
- Publication type:
- journal article
14
Antihypertensive treatment with and without benazepril in patients with chronic renal insufficiency: a US economic evaluation.
- Published in:
- 2002
- By:
- Publication type:
- journal article
15
Economic impact of low dose polyethylene glycol 3350 plus electrolytes compared with lactulose in the management of idiopathic constipation in the UK.
- Published in:
- 2002
- By:
- Publication type:
- journal article
16
Economic comparison of leflunomide and methotrexate in patients with rheumatoid arthritis: an evaluation based on a 1-year randomised controlled trial.
- Published in:
- 2002
- By:
- Publication type:
- journal article